APA (7th ed.) Citation

Zhao-Jun Mo, Zhao-Feng Bi, Wei Sheng, Qi Chen, Teng Huang, Ming-Qiang Li, . . . Ning-Shao Xia. (2022). Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Zhao-Jun Mo, et al. Safety and Immunogenicity of an Escherichia Coli-produced Bivalent Human Papillomavirus Type 6/11 Vaccine: A Dose-escalation, Randomized, Double-blind, Placebo-controlled Phase 1 Trial. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Zhao-Jun Mo, et al. Safety and Immunogenicity of an Escherichia Coli-produced Bivalent Human Papillomavirus Type 6/11 Vaccine: A Dose-escalation, Randomized, Double-blind, Placebo-controlled Phase 1 Trial. Taylor & Francis Group, 2022.